Clinical Coagulation, Malmö
261 – 270 of 630
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events
(
- Contribution to journal › Scientific review
-
Mark
Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
Thrombin generation in two families with MYH9-related platelet disorder.
(
- Contribution to journal › Article
-
Mark
Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum.
(
- Contribution to journal › Article
-
Mark
ABC om Yrsel på akuten
(
- Contribution to journal › Article
-
Mark
Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
(
- Contribution to journal › Article
- 2014
-
Mark
Introduction.
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.
(
- Contribution to journal › Article
-
Mark
Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method.
(
- Contribution to journal › Scientific review
-
Mark
Bleeding complications related to warfarin treatment: a descriptive register study from the anticoagulation clinic at Helsingborg Hospital
(
- Contribution to journal › Article